Related Experiment Video
Updated: Jun 19, 2026
11:47
Using 2-Photon Microscopy to Quantify the Effects of Chronic Unilateral Ureteral Obstruction on Glomerular Processes
Published on: March 4, 2022
THE EFFECT ON THE RATE OF UREA EXCRETION OF CARMINE DEPOSITION IN THE CELLS OF THE RENAL TUBULES
1Department of Medicine of Stanford University Medical School, San Francisco.
The Journal of Experimental Medicine
|October 30, 2009
Summary
Kidney tubule cells absorb urea. Damage to these cells, caused by carmine deposition, impairs urea reabsorption, increasing urea excretion into urine.
Area of Science:
- Nephrology
- Renal Physiology
- Urea Transport
Background:
- Urea is present in high concentrations within kidney convoluted tubule cells.
- These cells play a crucial role in filtering blood and forming urine.
Purpose of the Study:
- To review evidence of urea transport in kidney tubule cells.
- To investigate the effect of cellular damage on urea excretion rates.
Main Methods:
- Reviewed existing evidence on urea presence and transport in convoluted tubule cells.
- Administered carmine to induce deposition and potential damage in tubule cells.
- Measured urea excretion rates relative to blood urea concentration.
Main Results:
- Deposition of carmine in convoluted tubule cells increased the rate of urea excretion.
- This increase was observed at a given blood urea concentration.
- The findings suggest interference with the normal reabsorptive function of tubule cells.
Conclusions:
- Damage or blockage of kidney convoluted tubule cells impairs urea reabsorption from glomerular filtrate.
- This impairment leads to a higher concentration of urea in the bladder urine for a given blood urea level.
Related Concept Videos
01:28Renal Drug Excretion: Tubular Secretion
Active tubular secretion is a robust, energy-demanding process that utilizes carrier systems to transport drugs into renal tubules. The active renal secretion systems include the organic anion transporter (OAT) for weak acids and the organic cation transporter (OCT) for weak bases. Structurally similar drugs can compete for the same transporter, potentially leading to drug accumulation and toxicity. However, this principle can be exploited therapeutically. One example is probenecid (Probalan),...
01:25Renal Drug Excretion: Tubular Reabsorption
Tubular reabsorption, a process occurring post-glomerular filtration of drugs in the renal tubule, is a critical determinant of drug half-life. During the process of renal excretion, as the glomerular filtrate progresses to the distal convoluted tubule (DCT), drugs that are highly permeable, lipophilic, and nonionized undergo passive reabsorption from the tubular fluid into the surrounding peritubular capillaries. This reabsorption process restricts their elimination through the kidneys. This...
01:15Drug Elimination by Renal Route: Tubular Secretion
Once the process of glomerular filtration is completed, blood carrying unfiltered drug molecules traverses through efferent arterioles and makes its way into the peritubular capillaries in the proximal tubule. A variety of carriers play a pivotal role in actively secreting drugs from these peritubular capillaries into the tubular fluid. The organic anion transporter transfers acidic drugs, against an electrochemical gradient, from the peritubular capillaries into the renal tubule cells and...
01:22Renal Drug Excretion: Effect of Urine pH, Flow Rate, and Drug pKa
The pH of urine, the drug's pKa, and the urine flow rate are vital parameters for drug reabsorption and excretion. Urinary pH varies between 4.6 and 8.0 and is influenced by diet, drug intake, and the patient's pathophysiology. It affects a drug's ionization state and reabsorption. For instance, carbohydrate-rich food produces alkaline urine promoting drug excretion, while proteins and certain medications like ascorbic acid lead to acidic urine enhancing reabsorption.
The pKa of a drug,...
The pKa of a drug,...
01:25Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant
In patients with renal disease, dosage adjustments are necessary to maintain therapeutic plasma drug concentrations and prevent toxicity or subtherapeutic exposure. Renal impairment alters drug pharmacokinetics, especially in conditions like uremia, where changes such as prolonged elimination half-life and altered apparent volume of distribution can significantly affect drug disposition. These changes require careful modification of the dosing regimen to achieve the desired clinical...
01:22Drug Elimination by Renal Route: Tubular Reabsorption
During the process of renal excretion, as the glomerular filtrate progresses to the distal convoluted tubule (DCT), drugs that are highly permeable, lipophilic, and nonionized undergo passive reabsorption from the tubular fluid into the surrounding peritubular capillaries. This reabsorption process restricts their elimination through the kidneys. However, the majority of drugs are either weak acids or weak bases, and their ionization level is dependent on pH. By altering the pH of urine, the...